SRPIN340

CAS No. 218156-96-8

SRPIN340( SRPK Inhibitor )

Catalog No. M13482 CAS No. 218156-96-8

SRPIN340 is a serine/arginine-rich protein kinase (SRPK)-specific inhibitor with an IC50 value of 0.89 uM (SRPK1).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 In Stock
5MG 57 In Stock
10MG 96 In Stock
25MG 177 In Stock
50MG 324 In Stock
100MG 421 In Stock
500MG 945 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SRPIN340
  • Note
    Research use only, not for human use.
  • Brief Description
    SRPIN340 is a serine/arginine-rich protein kinase (SRPK)-specific inhibitor with an IC50 value of 0.89 uM (SRPK1).
  • Description
    SRPIN340 is a serine/arginine-rich protein kinase (SRPK)-specific inhibitor with an IC50 value of 0.89 uM (SRPK1); no significant inhibitory activity against more than 140 other kinases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SRPK Inhibitor
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Serine Protease
  • Recptor
    SRPK1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    218156-96-8
  • Formula Weight
    349.35
  • Molecular Formula
    C18H18F3N3O
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 70 mg/mL (200.37 mM); DMSO: 70 mg/mL (200.37 mM)
  • SMILES
    O=C(C1=CC=NC=C1)NC2=CC(C(F)(F)F)=CC=C2N3CCCCC3
  • Chemical Name
    N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl)isonicotinamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fukuhara T, et al. Proc Natl Acad Sci U S A. 2006, 103(30), 11329-11333.
molnova catalog
related products
  • MEGA-9

    MEGA-9 solubilizes membrane protein and can be used as a nonionic detergent.

  • JCP174

    JCP174 is a depalmitoylase inhibitor that enhances Toxoplasma host-cell invasion by targeting TgPPT1.

  • SLK/STK10-IN-1

    SLK/STK10-IN-1 is a selective and potent inhibitor of SLK and STK10 with potential antitumor activity.